Akbulut Caliskan O - Search Results

Save citations to file

Your saved search

Your RSS Feed

Page 1

HER2-targeted therapy in colorectal cancer: a comprehensive review.

Benli Y, Arıkan H, Akbulut-Çalışkan Ö. Benli Y, et al. Among authors: akbulut caliskan o. Clin Transl Oncol. 2025 Mar 14. doi: 10.1007/s12094-025-03887-0. Online ahead of print. Clin Transl Oncol. 2025. PMID: 40087250 Review.

Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer.

Gedik ME, Saatci O, Oberholtzer N, Uner M, Akbulut Caliskan O, Cetin M, Aras M, Ibis K, Caliskan B, Banoglu E, Wiemann S, Üner A, Aksoy S, Mehrotra S, Sahin O. Gedik ME, et al. Among authors: akbulut caliskan o. Cancer Res. 2024 May 2;84(9):1475-1490. doi: 10.1158/0008-5472.CAN-23-2812. Cancer Res. 2024. PMID: 38319231 Free PMC article.

EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers.

Cicek E, Circir A, Oyken M, Akbulut Caliskan O, Dioken DN, Guntekin Ergun S, Cetin-Atalay R, Sapmaz A, Ovaa H, Sahin O, Erson-Bensan AE. Cicek E, et al. Among authors: akbulut caliskan o. Oncogene. 2022 Jan;41(2):220-232. doi: 10.1038/s41388-021-02086-9. Epub 2021 Oct 30. Oncogene. 2022. PMID: 34718348 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters